C difficile Vaccine: CLOVER Trial Shows Mixed Results
There's mixed news from Pfizer on results from the CLOVER trial of their candidate vaccine for preventing C diff infection.
Source: medscape.com
Stay updated with breaking news from David Aronoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There's mixed news from Pfizer on results from the CLOVER trial of their candidate vaccine for preventing C diff infection.
Studies suggest that certain blood types may leave you more at risk of COVID-19. See what the science says so far—and why people with Type O still need masks.
David Aronoff, MD, discusses the benefits of booster shots
David Aronoff, MD, discusses an early study on CBD and on how to address interested patients
We may always have one variant or another, some health experts say